Cellectis S.A.EURONEXT: ALCLS

Monthly information on share capital and company voting rights

· Issued by Cellectis S.A. via GlobeNewswire

Summary by 6ix AI

Cellectis reported that as of September 30, 2026, its share capital was made up of 100,732,781 shares, carrying a total of 105,563,044 voting rights.

Key details

  • The monthly disclosure is made under Article 223-16 of the General Regulation of the French financial markets authority.
  • Cellectis shares are listed on the Euronext Growth market under ISIN code FR0010425595, an international identifying number for securities.

6ix AI wrote this summary from the release below and checked it against the release.

On 6ix: 6ix.com/news/monthly-information-on-share-capital-and-company-voting-rights-1

Watch Cellectis' latest callCellectis (Euronext:ALCLS) Q1 2026 Earnings Call · Replay · May 11Read the transcript of Cellectis (Euronext:ALCLS) Q1 2026 Earnings Call

Cellectis Inc.

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, Oct. 06, 2026 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date

Total number of shares
in the capital

Total number of voting rights

09/30/2026

100,732,781

105,563,044

For further information on Cellectis, please contact:

Media contacts:             
Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33, [email protected]  
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contact:          
Arthur Stril, Chief Financial Officer & Chief Business Officer, [email protected]

Attachment

Cellectis S.A. on 6ix

Earlier from Cellectis

Later from Cellectis

All Cellectis news releases